Send mail to Author

An open-label trial of 12-week Simeprevir plus Peginterferon/Ribavirin (PR) in treatment-naïve patients with hepatitis C Virus (HCV) genotype 1 (GT1) (Article)

Please indicate your contact information and select, which author you want to contact.



 
  _  _      ___      _  _      ___      _____    __   __  
 | \| ||   / _ \\   | \| ||   / _ \\   / ____||  \ \\/ // 
 |  ' ||  / //\ \\  |  ' ||  / //\ \\ / //---`'   \ ` //  
 | .  || |  ___  || | .  || |  ___  ||\ \\___      | ||   
 |_|\_|| |_||  |_|| |_|\_|| |_||  |_|| \_____||    |_||   
 `-` -`  `-`   `-`  `-` -`  `-`   `-`   `----`     `-`'
 


Back to frontdoor view

OPUS4 Logo